...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Promissory Note
Reply New Message
Back To Forum List View
Icon president Promissory Note
6
RVXoldtimer
Mar 09, 2021 04:20PM
Re: Promissory Note
4
narmac
Mar 09, 2021 08:47PM
Re: Promissory Note
3
KOO-KOO2
Mar 10, 2021 07:12AM
Re: Promissory Note
1
Telepanel
Mar 10, 2021 07:19AM
Icon president Re: Promissory Note
1
RVXoldtimer
Mar 10, 2021 01:17PM

Would really like to know what's going on with Zenith regarding a buyout...we've heard discussion on this for a long time....any rumors on something during 2021?

Would Zenith fetch over $10.00 per share on competitive bidding...we've had no negative information on Zenith and cancer related drugs are in vogue now...any thoughts or comments?

3 Recommendations
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply